These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 3031871)

  • 21. Yeast-secreted bovine herpesvirus type 1 glycoprotein D has authentic conformational structure and immunogenicity.
    Zhu X; Wu S; Letchworth GJ
    Vaccine; 1997; 15(6-7):679-88. PubMed ID: 9178470
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antibody responses by cattle after vaccination with commercial viral vaccines containing bovine herpesvirus-1, bovine viral diarrhea virus, parainfluenza-3 virus, and bovine respiratory syncytial virus immunogens and subsequent revaccination at day 140.
    Fulton RW; Confer AW; Burge LJ; Perino LJ; d'Offay JM; Payton ME; Mock RE
    Vaccine; 1995; 13(8):725-33. PubMed ID: 7483787
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antibody response to rubella virus proteins in different physical forms.
    Trudel M; Nadon F; Comtois R; Ravaoarinoro M; Payment P
    Antiviral Res; 1982 Dec; 2(6):347-54. PubMed ID: 7165297
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mucosal and systemic immunity to bovine herpesvirus-1 glycoprotein D confer resistance to viral replication and latency in cattle.
    Zhu X; Letchworth GJ
    Vaccine; 1996 Jan; 14(1):61-9. PubMed ID: 8821651
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Construction of a recombinant BHV-1 expressing the VP1 gene of foot and mouth disease virus and its immunogenicity in a rabbit model.
    Ren XG; Xue F; Zhu YM; Tong GZ; Wang YH; Feng JK; Shi HF; Gao YR
    Biotechnol Lett; 2009 Aug; 31(8):1159-65. PubMed ID: 19343503
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immune recognition pattern of bovid herpesvirus 1-infected rabbits against major glycoproteins.
    Okazaki K; Watanabe M; Honda E; Kumagai T
    J Vet Med Sci; 1991 Feb; 53(1):137-9. PubMed ID: 1650595
    [No Abstract]   [Full Text] [Related]  

  • 27. The role of carbohydrate in the antigenic and immunogenic structure of bovine herpesvirus type 1 glycoproteins gI and gIV.
    van Drunen Littel-van den Hurk S; Hughes G; Babiuk LA
    J Gen Virol; 1990 Sep; 71 ( Pt 9)():2053-63. PubMed ID: 1698921
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A live bovine herpesvirus-1 marker vaccine is not shed after intramuscular vaccination.
    Makoschey B; Beer M
    Berl Munch Tierarztl Wochenschr; 2007; 120(11-12):480-2. PubMed ID: 18085158
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A combined bovine herpesvirus 1 gB-gD DNA vaccine induces immune response in mice.
    Caselli E; Boni M; Di Luca D; Salvatori D; Vita A; Cassai E
    Comp Immunol Microbiol Infect Dis; 2005 Mar; 28(2):155-66. PubMed ID: 15582691
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Anti-bovine herpesvirus and anti-bovine viral diarrhea virus antibody responses in pregnant Holstein dairy cattle following administration of a multivalent killed virus vaccine.
    Smith BI; Rieger RH; Dickens CM; Schultz RD; Aceto H
    Am J Vet Res; 2015 Oct; 76(10):913-20. PubMed ID: 26413830
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neutralizing antibody responses in preconditioned calves following vaccination for respiratory viruses.
    Grooms DL; Coe P
    Vet Ther; 2002; 3(2):119-27. PubMed ID: 19750742
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunogenicity of a modified-live virus vaccine against bovine viral diarrhea virus types 1 and 2, infectious bovine rhinotracheitis virus, bovine parainfluenza-3 virus, and bovine respiratory syncytial virus when administered intranasally in young calves.
    Xue W; Ellis J; Mattick D; Smith L; Brady R; Trigo E
    Vaccine; 2010 May; 28(22):3784-92. PubMed ID: 20381643
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Polynucleotide vaccines in animals: enhancing and modulating responses.
    Lewis PJ; Cox GJ; van Drunen Littel-van den Hurk S; Babiuk LA
    Vaccine; 1997 Jun; 15(8):861-4. PubMed ID: 9234534
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of BHV-1 antibody titer in a cattle herd against different BHV-1 strains.
    Lee M; Reed A; Estill C; Izume S; Dong J; Jin L
    Vet Microbiol; 2015 Sep; 179(3-4):228-32. PubMed ID: 26123370
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Persistence of bovine herpesvirus-1-specific antibodies in cattle after intranasal vaccination with a live virus vaccine.
    Van der Poel WH; Kramps JA; Quak J; Brand A; Van Oirschot JT
    Vet Rec; 1995 Sep; 137(14):347-8. PubMed ID: 8560685
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of experimental subunit vaccines for infectious bovine rhinotracheitis.
    Lupton HW; Reed DE
    Am J Vet Res; 1980 Mar; 41(3):383-90. PubMed ID: 6245609
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunoglobulin M (IgM) indirect enzyme-linked immunosorbent assay and the involvement of IgM-rheumatoid factor in the serodiagnosis of BHV-1 infection.
    Ungar-Waron H; Abraham A
    Vet Microbiol; 1991 Jan; 26(1-2):53-63. PubMed ID: 1850891
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A conventionally attenuated glycoprotein E-negative strain of bovine herpesvirus type 1 is an efficacious and safe vaccine.
    Kaashoek MJ; Moerman A; Madić J; Rijsewijk FA; Quak J; Gielkens AL; van Oirschot JT
    Vaccine; 1994 Apr; 12(5):439-44. PubMed ID: 8023552
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation in swine of a subunit vaccine against pseudorabies.
    Maes RK; Schutz JC
    Am J Vet Res; 1983 Jan; 44(1):123-5. PubMed ID: 6297337
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characterization of an iscom prepared with envelope glycoproteins of bovine herpesvirus type 1.
    Merza M; Belak S; Morein B
    Zentralbl Veterinarmed B; 1988 Nov; 35(9):695-703. PubMed ID: 2849843
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.